Related Experiment Video
Updated: Jul 17, 2026
10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters KCa2.2 vs. KCa3.1 Ligand Selectivity
Matteo Gozzi1,2, Joana Massa1,2, Oliver Koch1,2
1GRK 2515, Chemical Biology of Ion Channels (Chembion), University of Münster, Münster, Germany.
Archiv Der Pharmazie
|July 16, 2026
Summary
Researchers identified a key protein difference, Ser353/Pro245, that dictates the selectivity of drugs targeting KCa2.2 and KCa3.1 channels, crucial for treating diseases like cancer.
Area of Science:
- Molecular biology
- Pharmacology
- Computational chemistry
Background:
- KCa2.2 and KCa3.1 channels regulate membrane potential and calcium signaling.
- These channels are therapeutic targets for spinocerebellar ataxia and cancer.
- Selective modulators are needed to fully exploit their therapeutic potential.
Purpose of the Study:
- Identify molecular determinants of KCa2.2 modulator selectivity.
- Analyze binding pockets of two specific KCa2.2 modulators.
- Understand structural differences between KCa2.2 and KCa3.1 binding sites.
Main Methods:
- In silico mutagenesis
- Molecular dynamics simulations
- Protein-ligand docking
Main Results:
- The Ser353/Pro245 substitution significantly alters KCa2.2 and KCa3.1 channel pocket shapes.
- This substitution is the primary driver of distinct modulator selectivity.
- Novel insights into KCa channel subtype binding site structural differences were gained.
Conclusions:
- The Ser353/Pro245 substitution is a key determinant of KCa2.2/KCa3.1 modulator selectivity.
- This finding aids in the rational design of selective KCa channel modulators.
- The study provides a framework for understanding structure-activity relationships in this channel class.
Related Concept Videos
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...